Title |
Alzheimer’s disease and cytokine IL-10 gene polymorphisms: is there an association?
|
---|---|
Published in |
Arquivos de Neuro-Psiquiatria, September 2017
|
DOI | 10.1590/0004-282x20170110 |
Pubmed ID | |
Authors |
Carolina Antunes Magalhães, Maria das Graças Carvalho, Lirlândia Pires de Sousa, Paulo Caramelli, Karina Braga Gomes |
Abstract |
Alzheimer's disease (AD) is the most common form of dementia. In the last 15 years, a new theory has proposed the autoimmune mechanism as a trigger for AD. Studies on the association between AD and inflammatory biomarkers have yielded controversial results. Interleukin-10 (IL-10), an anti-inflammatory mediator, has been pointed out as one of the main cytokines associated with the occurrence of AD. Moreover, treatment that increases IL-10 levels could be a potential therapy for AD, since this cytokine acts on amyloid and pro-inflammatory molecule reduction. Based on the current literature, this study reviews evidence regarding the role of IL-10 polymorphisms in the context of AD, which has been shown to be of paramount importance for attenuating neuroinflammation, cognitive dysfunction and neurodegeneration. |
X Demographics
Geographical breakdown
Country | Count | As % |
---|---|---|
Malaysia | 1 | 50% |
United States | 1 | 50% |
Demographic breakdown
Type | Count | As % |
---|---|---|
Members of the public | 2 | 100% |
Mendeley readers
Geographical breakdown
Country | Count | As % |
---|---|---|
Unknown | 65 | 100% |
Demographic breakdown
Readers by professional status | Count | As % |
---|---|---|
Student > Bachelor | 10 | 15% |
Other | 7 | 11% |
Student > Ph. D. Student | 7 | 11% |
Student > Master | 5 | 8% |
Researcher | 3 | 5% |
Other | 7 | 11% |
Unknown | 26 | 40% |
Readers by discipline | Count | As % |
---|---|---|
Neuroscience | 9 | 14% |
Biochemistry, Genetics and Molecular Biology | 8 | 12% |
Medicine and Dentistry | 6 | 9% |
Chemistry | 3 | 5% |
Agricultural and Biological Sciences | 3 | 5% |
Other | 7 | 11% |
Unknown | 29 | 45% |